Stay updated on Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial page.

Latest updates to the Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page footer now shows Revision: v3.3.3, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.3.2 is now shown on the page history, replacing Revision: v3.3.1.SummaryDifference0.0%

- Check45 days agoChange DetectedA new revision, v3.3.1, was added and v3.2.0 was removed in the record history. This is a housekeeping update to the history and does not modify trial data, eligibility, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedThe funding/operational status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check66 days agoChange DetectedNew screenshot shows a UI refresh of the Record History page with the same list of version entries, and underlying trial data appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check95 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference8%

Stay in the know with updates to Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial page.